Percival N, George A, Gyertson J, Hamill M, Fernandes A, Davies E, Rahman N, and Banerjee S. (2016) The integration of BRCA testing into oncology clinics. British Journal of Nursing 25(12):690-4
Eccleston A, Bentley A, Dyer M, Strydom A, Vereecken W, George A, and Rahman N. (2016) A discrete event simulation to evaluate the cost effectiveness of germline BRCA1 and BRCA2 testing in UK women with ovarian cancer. BioRxiv 060418; doi: http://dx.doi.org/10.1101/060418 Epub ahead of print.
George A, Riddell D, Seal S, Talukdar S, Mahamdallie S, Ruark E, Cloke V, Slade I, Kemp Z, Gore M, Strydom A, Banerjee S, Hanson H, and Rahman N. (2016) Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients. Scientific Reports 6: 29506
Rahman, N. (2014) Realizing the promise of cancer predisposition genes. Nature 505:302-308.
Rahman, N. (2014) Mainstreaming genetic testing of cancer predisposition genes. Clinical Medicine 14(4):436-439
Slade I, Hanson H, George A, Kohut K, Strydom A, Wordsworth S, and Rahman N. (2016) A cost analysis of a cancer genetic service model in the UK. Journal of Community Genetics 7 (3): 185-194
Slade I, Riddell D, Turnbull C, Hanson H, and Rahman N for the MCG programme. (2015) Development of cancer genetic services in the UK: A national consultation. Genome Medicine 7:18.
Münz M, Ruark E, Renwick A, Ramsay E, Clarke M, Mahamdallie S, Cloke V, Seal S, Strydom A, Lunter G, and Rahman N. (2015) CSN and CAVA: variant annotation tools for rapid, robust next-generation sequencing analysis in the clinical setting. Genome Medicine 7:76.
Press releases and information packs
Mar 2015 – MCG Information Pack
Jan 2014 – ‘A new pathway for cancer gene testing successfully completes pilot’ – Information Pack
Jan 2014 – ‘A new pathway for cancer gene testing successfully completes pilot’ – Press Release
May 2013 – MCG Launch Press Release
Nov 2015 – Cancer Predisposition Genes on the TruSight Cancer panel version 2
Jan 2015 – Would you have your genome sequenced? Let us know by completing our short survey
Jul 2014 – Wellcome Trust Centre for Human Genetics (WTCHG) High-Throughput Sequencing Tools
Jan 2013 – Methodology for selection of TruSight Cancer panel content
Jan 2013 – Cancer Predisposition Genes on the TruSight Cancer panel
To see what other people are saying about the MCG programme, see our In the News page.